Stock listing

Arecor Therapeutics Plc

Selected listing: 6UI · SWB · EUR · DE

Arecor Therapeutics Plc (Stuttgart:6UI), Health Technology. Latest release Sep 30, 2026: Retail Offer to raise up to £130,000.

6UI:SWBEURDEUpdated September 25, 2026

Ticker: Stuttgart:6UI
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Stuttgart
Currency: EUR

About Arecor Therapeutics Plc

The company focuses on developing innovative therapeutic solutions, leveraging its proprietary technology platform. Arecor aims to enhance the performance of existing medicines to improve patient outcomes.

Latest news from Arecor Therapeutics Plc

Retail Offer to raise up to £130,000

September 30, 2026

Results of Placing

September 30, 2026

Close of Accelerated Bookbuild to New Orders

September 30, 2026

Proposed Fundraising to raise up to £5.13 million

September 30, 2026

Interim results for the six months to 30 June 2026

September 30, 2026

All Arecor Therapeutics Plc news →

Events

Replays

Arecor Therapeutics plc (AREC) Q4 2025 Earnings Call
Thu, Apr 23, 2026 · 06:00 AM ET
Watch
ARECOR THERAPEUTICS PLC (AREC) — Arecor Interim Results, Co-development Agreement & Sale of Royalty and Technology Access Fees
Thu, Oct 02, 2025 · 06:00 AM ET
Watch
ARECOR THERAPEUTICS PLC (AREC) — Final Results Results for the year ended 31 December 2024
Thu, May 01, 2025 · 09:00 AM ET
Watch

Research Arecor Therapeutics Plc

Arecor Therapeutics Plc company profile

View the public company page for Arecor Therapeutics Plc on 6ix.

Arecor Therapeutics Plc news

Read company news and market updates connected to Arecor Therapeutics Plc.

Arecor Therapeutics Plc investor events

Find investor webinars, events, and replay context for Arecor Therapeutics Plc.